Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2018-07
-
EZ Cap™ Mouse IL-12 mRNA (m1Ψ): Engineering Resilient Cytoki
2026-07-23
Discover how EZ Cap™ Mouse IL-12 mRNA (m1Ψ) empowers advanced immunotherapy research by enabling robust, stable cytokine expression with minimal innate immune activation. This article offers a deep dive into delivery mechanics, translational limitations, and new frontiers in immune modulation.
-
AZD8055: Technical Parameters for mTOR Inhibition in Researc
2026-07-23
AZD8055 is a potent, selective ATP-competitive mTOR inhibitor designed for robust inhibition of both mTORC1 and mTORC2 in preclinical research. It is best suited for mechanistic studies of mTOR signaling and cancer cell proliferation in cell-based and animal models, but is not recommended where clinical efficacy or water solubility is required.
-
BCECF for Translational Research: Precision pH Sensing Reima
2026-07-22
Explore how BCECF (2',7'-bis(carboxyethyl)-5(6)-Carboxyfluorescein) empowers translational researchers to dissect extracellular pH dynamics in complex disease models. By integrating mechanistic insights from neuropathic pain research, benchmarking performance, and delivering actionable protocol guidance, this article provides a unique, strategic roadmap for leveraging advanced pH measurement tools in preclinical and translational workflows. Discover how APExBIO’s BCECF stands apart from standard solutions and what the future holds for precision pH sensing.
-
Iptacopan (LNP023): Translating Factor B Inhibition Into Cli
2026-07-22
Explore the unique pharmacological and translational profile of Iptacopan (LNP023), a selective oral complement factor B inhibitor. This article delivers a deep dive into its mechanism, therapeutic potential, and clinical evidence—offering practical insights beyond protocol guides.
-
EV-Transferred ACLY Drives Macrophage Immunosuppression in H
2026-07-21
This study reveals that hepatocellular carcinoma (HCC) cells secrete extracellular vesicles (EVs) containing ATP-citrate lyase (ACLY), which are taken up by monocytes and induce their differentiation into immunosuppressive tumor-associated macrophages (TAMs). The findings elucidate a metabolic pathway for TAM formation in the tumor microenvironment and highlight ACLY as a promising therapeutic target to enhance immunotherapy efficacy in HCC.
-
Inducing Bleb Structures in LNP-mRNA Boosts Transfection Pot
2026-07-21
A recent study demonstrates that formulating lipid nanoparticle (LNP) mRNA systems to induce mRNA-rich bleb structures—specifically by using high-concentration pH 4 sodium citrate buffers—substantially enhances transfection efficiency in vitro and in vivo. This finding highlights the importance of formulation parameters in optimizing mRNA delivery, with implications for both therapeutic development and experimental gene expression assays.
-
Affordable GRO-seq Profiling of Nascent RNAs in Bread Wheat
2026-07-20
Chen et al. introduce a cost-efficient GRO-seq protocol for bread wheat that significantly increases valid nascent RNA sequencing data by incorporating an rRNA removal step. This advance enables high-resolution mapping of transcriptional activity in complex plant genomes while reducing resource barriers for transcriptomic research.
-
BX795 in Translational Research: Unlocking PDK1 and Innate I
2026-07-20
This thought-leadership article explores the mechanistic and strategic value of BX795, a potent PDK1 inhibitor, in advancing in vitro cancer and innate immune response research. We bridge new mechanistic evidence, highlight best-practice protocols, and provide translational researchers actionable strategies to exploit BX795’s dual-action profile. By contextualizing recent findings in drug response metrics and integrating insights from advanced workflow literature, we offer a forward-looking perspective that surpasses conventional product summaries.
-
Applied Silymarin Research: Silybin A for Liver and Metaboli
2026-07-19
Silybin A, the active component of Silymarin, unlocks advanced liver disease and metabolic research with high-purity, reproducible performance. This article details optimized workflows, troubleshooting strategies, and novel protocol enhancements, empowering scientists to maximize data quality and biological relevance in hepatoprotection and oxidative stress studies.
-
Nystatin (Fungicidin): Mechanistic Insights and Research Fro
2026-07-18
Explore the unique antifungal mechanisms and advanced research applications of Nystatin (Fungicidin), including its impact on Candida species, mycoplasma, and infection modeling. This article offers new technical perspectives and practical guidance for optimizing experimental design.
-
Merbromin as a Selective Mixed-Type Inhibitor of SARS-CoV-2
2026-07-17
A recent study identified Merbromin (Mercury dibromofluorescein disodium salt) as a potent, selective mixed-type inhibitor of the SARS-CoV-2 main protease 3CLpro, using high-throughput screening and kinetic analysis. These findings offer mechanistic insight and a foundation for antiviral drug design targeting coronavirus proteases.
-
EZ Cap™ Firefly Luciferase mRNA: Optimizing Reporter Assays
2026-07-17
EZ Cap™ Firefly Luciferase mRNA with Cap 1 structure enables high-sensitivity, low-immunogenicity reporter assays for translational biology. Explore proven protocols, workflow innovations, and troubleshooting strategies to maximize bioluminescent signal and reproducibility in both in vitro and in vivo applications.
-
Oleanolic Acid in Dual-Loaded Liposome Workflows: iNOS Induc
2026-07-16
Oleanolic acid, a DMSO-soluble natural triterpenoid, enables robust dual-loaded liposome workflows for antiviral and immune modulation research. Leveraging innovations in encapsulation efficiency assessment, researchers can now optimize co-delivery strategies and troubleshoot complex formulations with precision.
-
Neuroligin 1 Proteolysis Regulates Social Memory Maintenance
2026-07-16
This study uncovers a novel mechanism by which social interactions trigger proteolytic processing of neuroligin 1 in the ventral hippocampus, generating intracellular fragments essential for maintaining social memory. The findings highlight how synaptic remodeling, mediated by NLG1-CTD and cofilin signaling, underpins memory persistence and suggest new molecular targets for neuropsychiatric research.
-
Recombinant Human Oncostatin M: Optimizing Cytokine Assays
2026-07-15
Recombinant Human Oncostatin M (E.coli, Tag Free, Lyophilized) from APExBIO empowers highly reproducible fibroblast proliferation and cytokine release assays with exceptional purity and activity. Discover advanced experimental workflows, troubleshooting strategies, and practical insights for reliable cell modulation studies.